PROF

Profound Medical Corp

6.81

Aug 25 • 3:59 PM ET +0.01 (0.15%)

6.81

Aftermarket • 4:15 PM ET 0.00 (0.00%)

Healthcare Medical Devices Canada Micro NASD

Peers: SI MASS RXST TLSI SENS APYX BFLY OFIX VMD ATEC

| Held by: QQQS DFIC

Scroll to Statements

Index	-
Market Cap	248.77M
Enterprise Value	217.88M
Income	-32.75M
Sales	19.09M
Book/sh	1.36
Cash/sh	1.05
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	162
IPO	Jun 09, 2016

P/E	-
Forward P/E	-
PEG	-
P/S	13.03
P/B	4.99
P/C	6.50
P/FCF	-
EV/EBITDA	-
EV/Sales	11.41
Quick Ratio	5.31
Current Ratio	6.46
Debt/Eq	0.15
LT Debt/Eq	0.06
Option/Short	Yes / Yes

EPS (ttm)	-0.99
EPS next Y	-0.59
EPS next Q	-0.23
EPS this Y	41.13%
EPS next Y	29.16%
EPS next 5Y	63.25%
EPS past 3/5Y	-0.76% -2.41%
Sales past 3/5Y	34.06% 17.12%
EPS Y/Y TTM	32.01%
Sales Y/Y TTM	61.19%
EPS Q/Q	49.75%
Sales Q/Q	12.30%
Earnings	Aug 06 AMC
EPS/Sales Surpr.	-7.22% -47.73%

Insider Own	2.97%
Insider Trans	0.00%
Inst Own	45.13%
Inst Trans	0.00%
ROA	-58.45%
ROE	-73.53%
ROIC	-62.30%
Gross Margin	71.79%
Oper. Margin	-185.31%
Profit Margin	-171.57%
SMA20	-5.44%
SMA50	-3.03%
SMA200	-1.04%
Trades

Shs Outstand	36.53M
Shs Float	35.45M
Short Float	5.19%
Short Ratio	19.96
Short Interest	1.84M
52W High	8.95 -23.91%
52W Low	3.76 81.12%
Volatility	5.38% 6.59%
ATR (14)	0.42
RSI (14)	45.07
Beta	0.72
Rel Volume	1.58
Avg Volume	92.26K
Volume	145,767

Perf Week	-2.71%
Perf Month	-7.09%
Perf Quarter	0.59%
Perf Half Y	-4.76%
Perf YTD	-13.47%
Perf Year	45.82%
Perf 3Y	-13.91%
Perf 5Y	-54.69%
Perf 10Y	-39.46%
Recom	1.00
Target Price	11.14
Prev Close	6.80
Price	6.81
Change %	0.15%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-27-26	Upgrade	Raymond James	Outperform → Strong Buy	$11
Jul-23-24	Initiated	Lake Street	Buy	$16.50
Jul-16-24	Upgrade	Stifel	Hold → Buy	$9 → $12
Nov-28-23	Initiated	Stifel	Hold	$11
Aug-04-23	Downgrade	Raymond James	Strong Buy → Outperform	$20 → $200
Mar-21-23	Downgrade	Jefferies	Buy → Hold	$5.50 → $10
Sep-15-20	Initiated	Jefferies	Buy

Aug-17-26 08:30AM	Profound's Introduction of New Real-time Interventional MRI Software Paving the Way for Full 'TULSA Days' (GlobeNewswire)
Aug-14-26 04:30PM	Profound Medical Announces Management Change (GlobeNewswire)
Aug-13-26 04:15PM	Profound Medical Launches 'Let's Huddle', a Global Community Supporting Men Throughout Their Prostate Care Journey (GlobeNewswire)
Aug-07-26 08:30AM	Profound Medical Corp. Q2 2026 Earnings Call Summary (Moby) -6.68%
01:09AM	Profound Medical Corp (PROF) (Q2 2026) Earnings Call Highlights: Record Orders and ... (GuruFocus.com)
04:12PM	Loading…
Aug-06-26 04:12PM	Profound Medical Reports Second Quarter 2026 Financial Results (GlobeNewswire)
Aug-05-26 09:40AM	Earnings To Watch: Profound Medical Corp (PROF) Q2 2026 -- GF Value Sees 226% Upside (GuruFocus.com)
Jul-24-26 10:15AM	Robotic Radical Prostatectomy Comes Up 'Short' in CAPTAIN Trial (GlobeNewswire) +5.99%
Jul-16-26 04:30PM	Profound Medical to Release Second Quarter 2026 Financial Results on August 6th - Conference Call to Follow (GlobeNewswire)
Jul-15-26 07:45AM	Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026 (GlobeNewswire)
May-20-26 04:49PM	Wall Street Analysts See a 59.68% Upside in Profound Medical (PROF): Can the Stock Really Move This High? (Quartz)
May-14-26 07:00AM	Profound to Showcase TULSA-PRO, the TULSA Procedure and the Future of iMRI at AUA2026 (GlobeNewswire)
May-13-26 08:41PM	Profound Medical Annual General and Special Meeting of Shareholders Voting Results (Newsfile)
May-07-26 04:05PM	Profound Medical Reports Strong First Quarter 2026 Financial Results (GlobeNewswire)
May-06-26 09:33AM	Profound Medical Corp (PROF) Q1 2026 Earnings Report Preview: What to Expect (GuruFocus.com)
10:30AM	Loading…
Apr-29-26 10:30AM	Why Medtech Giants Are Quietly Paying Up for AI Diagnostics (PR Newswire)
Apr-16-26 08:37AM	Profound Medical to Release First Quarter 2026 Financial Results on May 7 - Conference Call to Follow (GlobeNewswire)
Apr-14-26 07:30AM	Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference (GlobeNewswire)
Apr-01-26 08:15AM	Incision-Free, MRI-Guided Prostate Treatment with Profound's TULSA-PRO to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting (GlobeNewswire)
Mar-27-26 07:45AM	Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure Milestone (GlobeNewswire)
Mar-13-26 10:30AM	CAPTAIN Trial Comparing Profound's MRI-Guided TULSA Procedure to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence (GlobeNewswire)
Mar-09-26 08:30AM	Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24 (GlobeNewswire)
Mar-06-26 12:02AM	Profound Medical Corp (PROF) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic ... (GuruFocus.com) -29.11%
Mar-05-26 11:06PM	Profound Medical Q4 Earnings Call Highlights (MarketBeat)
05:20PM	Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Mar-04-26 07:22AM	Profound Medical Corp (PROF) Q4 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Mar-02-26 10:00AM	ARS Pharmaceuticals, Inc. (SPRY) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
08:06AM	Xeris Biopharma (XERS) Q4 Earnings and Revenues Surpass Estimates (Zacks)
Feb-26-26 10:00AM	Earnings Preview: Profound Medical (PROF) Q4 Earnings Expected to Decline (Zacks) +5.07%
08:15AM	Loading…
08:15AM	Aurinia Pharmaceuticals (AUPH) Tops Q4 Earnings and Revenue Estimates (Zacks)
Feb-25-26 12:15PM	Acadia Healthcare (ACHC) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
Feb-12-26 04:30PM	Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th - Conference Call to Follow (GlobeNewswire) +5.94%
08:30AM	Profound Medical Honored with INOVAIT's 2025-2026 Mount Logan Award Recognizing the TULSA Procedure for Prostate Disease (GlobeNewswire)
Feb-05-26 08:00AM	PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve Procedures, Expanding Access to Incision-Free Care for Women's Health (GlobeNewswire) -7.33%
Jan-27-26 04:30PM	Profound Medical Announces Upcoming Investor Events (GlobeNewswire)
Jan-16-26 08:55AM	Profound Medical (PROF) Soars 9.5%: Is Further Upside Left in the Stock? (Zacks)
Jan-15-26 09:26AM	Strength Seen in Ocular Therapeutix (OCUL): Can Its 6.1% Jump Turn into More Strength? (Zacks) +9.45%
07:30AM	Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO (GlobeNewswire)
Jan-12-26 08:00AM	Profound Surpasses 2025 TULSA-PRO Installed Base Goal (GlobeNewswire)
Jan-06-26 07:45AM	Johns Hopkins Medicine Treats First Commercial TULSA-PRO Case (GlobeNewswire)
Dec-30-25 04:30PM	Profound Medical Corp. Announces Closing of Private Placement (GlobeNewswire) +7.37%
Dec-24-25 01:15PM	Profound Medical Corp. Announces Upsize of Private Placement (GlobeNewswire)
Dec-23-25 08:00AM	Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th (GlobeNewswire)
Dec-19-25 08:45AM	Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement (GlobeNewswire)
Dec-05-25 09:55AM	Wall Street Analysts Think Profound Medical (PROF) Could Surge 82.37%: Read This Before Placing a Bet (Zacks)
Dec-04-25 05:00PM	Stanford Medicine's Dr. Pejman Ghanouni Receives RSNA's Cum Laude Award for CAPTAIN Perioperative Data Presentation (GlobeNewswire)
Nov-28-25 07:45AM	Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO Clinical Data, at RSNA and SUO Meetings (GlobeNewswire)
Nov-24-25 09:55AM	Profound Medical (PROF) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? (Zacks)
09:55AM	Profound Medical (PROF) Just Flashed Golden Cross Signal: Do You Buy? (Zacks)
Nov-19-25 12:00PM	Profound Medical (PROF) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
09:55AM	Wall Street Analysts Believe Profound Medical (PROF) Could Rally 97.59%: Here's is How to Trade (Zacks)
Nov-18-25 04:15PM	Profound Medical Celebrates The Hong Center's 200th Independent TULSA Procedure for Prostate Disease (GlobeNewswire)
Nov-13-25 05:20PM	Profound Medical (PROF) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +7.87%
04:05PM	Profound Medical Reports Strong Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-12-25 08:30AM	Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO to Australia and New Zealand (GlobeNewswire)
07:29AM	Profound Medical Corp (PROF) Q3 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Nov-11-25 04:15PM	Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO and Sonalleve with Al Faisaliah Medical Systems in Saudi Arabia (GlobeNewswire) +7.26%
Nov-10-25 04:30PM	Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO in Canada from Knight (GlobeNewswire)
Oct-16-25 08:00AM	Profound Medical Congratulates the Busch Center for Achieving 500th TULSA Procedure Milestone (GlobeNewswire)
Oct-14-25 08:30AM	Profound Medical to Participate in the Stifel 2025 Healthcare Conference (GlobeNewswire)
Oct-07-25 07:45AM	Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter (GlobeNewswire) +11.76%
Sep-23-25 08:00AM	Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment (GlobeNewswire) +17.67%
Aug-28-25 08:00AM	Profound Medical to Participate in Lake Street's 9th Annual Best Ideas Growth Conference (GlobeNewswire)
Aug-15-25 04:25PM	Zevra Therapeutics (ZVRA) Reports Q2 Loss, Tops Revenue Estimates (Revised) (Zacks) -23.29% +11.76%
03:23AM	Profound Medical Corp (PROF) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
Aug-14-25 05:20PM	Profound Medical (PROF) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Profound Medical Announces Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-12-25 05:50PM	Zevra Therapeutics (ZVRA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Aug-07-25 06:35PM	Relay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
Aug-05-25 08:15AM	Madrigal (MDGL) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Jul-24-25 05:00PM	Profound Medical to Release Second Quarter 2025 Financial Results on August 14 - Conference Call to Follow (GlobeNewswire)
Jun-25-25 04:09AM	Profound Medical Completes First Commercial BPH Treatment With New TULSA-AI Volume Reduction Module (Insider Monkey)
Jun-10-25 08:00AM	Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO with TULSA-AI Volume Reduction (GlobeNewswire) +17.39%
Jun-04-25 07:45AM	Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO (GlobeNewswire)
May-14-25 04:45PM	Profound Medical Annual General and Special Meeting of Shareholders Voting Results (GlobeNewswire) -5.39% +12.13%
May-09-25 03:40AM	Profound Medical Corp (PROF) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... (GuruFocus.com) -7.03%
May-08-25 06:20PM	Profound Medical (PROF) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Profound Medical Announces First Quarter 2025 Financial Results (GlobeNewswire)
May-07-25 11:16AM	Profound Medical Corp (TSX:PRN) Q1 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
May-05-25 09:57AM	Strength Seen in Profound Medical (PROF): Can Its 8.3% Jump Turn into More Strength? (Zacks)
Apr-30-25 05:55PM	Profound Medical: In Serious Trouble Despite Projected Growth (Seeking Alpha)
04:30PM	Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference (GlobeNewswire)
Apr-29-25 07:30AM	Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy (GlobeNewswire)
Apr-17-25 08:00AM	Profound Medical to Release First Quarter 2025 Financial Results on May 8 - Conference Call to Follow (GlobeNewswire)
Apr-15-25 07:45AM	Profound Medical AUA 2025 Investor Event Agenda (GlobeNewswire)
Mar-26-25 09:59PM	Wolf Haldenstein Adler Freeman & Herz LLP is investigating Profound Medical Corp. for potential violations of securities laws (GlobeNewswire)
Mar-25-25 08:00AM	Save the Date: Profound Medical to Host Investor Event at AUA 2025 (GlobeNewswire)
Mar-07-25 02:16AM	Profound Medical Corp (PROF) Q4 2024 Earnings Call Highlights: Record Revenue and Improved ... (GuruFocus.com) -5.90%
Mar-06-25 04:05PM	Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-05-25 07:23AM	What To Expect From Profound Medical Corp (TSX:PRN) Q4 2024 Earnings (GuruFocus.com)
Feb-13-25 05:00PM	Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 Conference Call to Follow (GlobeNewswire) +6.52%
Jan-13-25 08:00AM	Update: Profound Medical's Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th (GlobeNewswire)
Jan-08-25 07:30AM	Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues (GlobeNewswire)
Jan-06-25 08:15AM	Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-10-24 09:55AM	Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares (GlobeNewswire)
Dec-06-24 09:31AM	Canadian Investment Regulatory Organization Trade Resumption - PRN (PR Newswire) -6.72%
09:15AM	Canadian Investment Regulatory Organization Trading Halt - PRN (PR Newswire)
09:04AM	Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares (GlobeNewswire)
Dec-05-24 04:48PM	Profound Medical Announces Proposed Public Offering of Common Shares (GlobeNewswire)

Profound Medical Corp. is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the ablation of diseased tissue utilizing its platform technologies. The firm's product, the TULSA-PRO system, combines real-time MRI, robotically driven transurethral sweeping action/thermal ultrasound, and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It is also focused on developing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. The company was founded on June 13, 2008 and is headquartered in Mississauga, Canada.

Ph.D.Dr. Arun Swarup Menawat MBA

PresidentDr. Mathieu Burtnyk Ph.D.

Investor RelationsMr. Stephen Kilmer

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PROF

Profound Medical Corp

Upgrade your Finviz experience